In our on-demand webinar you can learn how you could emulate Bayer’s success, and how they are continuing to use E-WorkBook to improve lab practices, increase laboratory efficiency and build a laboratory environment suited for business needs both now and in the future.
Explore an approach to interpret the extractables data generated for single-use components used in biopharmaceutical processes by adopting the BPOG (BioPhorum Operations Group) protocol as a baseline testing strategy.
A new single-use (per batch) chromatography platform employs traditional, proven chemistries in an inventive hydrogel polymer membrane format that enables the next generation bioprocessing paradigm.
A webinar to learn about challenges faced with traditional expression systems and how a CHO cell line with the glutamine synthetase knock-out via ZFN provides benefits for fast, efficient cell line development with stable and high titer expression.
Learn about polishing technologies that enable a fully flow through polishing platform and how implementation of next generation processing can positively impact facility fit limitations.
Explore the economic benefits when using a cell culture medium designed specifically for perfusion processes and the proactive risk measures suppliers need to take to facilitate the manufacturer’s business continuity and product quality.
Using workflow based software solutions to guide scientists through various processes in low to high throughput screening campaigns.
This webinar explores use cases showing how machine learning and analytics can help overcome the challenges facing the biopharma industry through more confident data-driven decisions.
Striving to bring the way we acquire, share and gain insights from scientific data, through a community and the framework for standardization and linked data.
Integrity testing is a critical operation, especially for sterilizing grade filters. When performed correctly, an integrity test is a fast, definitive, non-destructive way to assure filter retention performance.
|
|
|
|
|
|
|
|
|